CA 125 (Ovaria CA) ECLIA

Starts at

₱ 1,400₱ 2,000

The CA 125 test measures a protein that may be elevated in ovarian cancer, as well as conditions like endometriosis or pelvic inflammation. Using advanced ECLIA technology, it delivers accurate and sensitive results.

While not used for diagnosis alone, it’s valuable for tracking ovarian cancer treatment, detecting recurrence, and evaluating related symptoms. It may also be recommended for those with a family history or genetic risk of ovarian cancer.

Additional Information

Test Requirements

No fasting required.
Do not take Biotin (Vitamin B7) for 8 hours prior to extraction.

How to Claim

FREE Hati Health Concierge Service

Frequently Asked Questions

What is Hati Health?

Hati Health is your digital health companion that connects you with trusted clinics and doctors across the Philippines. We make booking appointments and accessing healthcare simple and convenient, all through our growing network of 100+ partners.

What are the participating clinics and locations?

We work with a growing network of trusted clinics nationwide, making it convenient to find quality care wherever you are. Just share what service you need and your location—we'll show you all the available options nearby.

What are your payment options?

We offer flexible payment options including GCash, credit/debit cards, and bank transfers, with installment plans through BillEase and GoTyme. While we don't accept insurance yet, our affordable prices are often lower than HMO networks, and we're working on future partnerships.

How do I contact Hati Health?

You can reach us through our support chat on the website, Messenger or email us at [email protected]. Our team is here to assist you.

More About This Product

Find best CA 125 (Ovaria CA) ECLIA price in the Philippines. The CA 125 (Ovarian CA) ECLIA test is a crucial blood test that measures the CA 125 protein levels, which can indicate the presence of ovarian cancer when elevated. Using cutting-edge ElectroChemiluminescence Immunoassay (ECLIA) technology, this test is recognized for its sensitive and accurate results. While elevated levels can suggest ovarian cancer, they may also arise due to conditions like endometriosis, pelvic inflammatory disease, or abdominal pain. This test is particularly beneficial for monitoring treatment progress in patients undergoing chemotherapy for ovarian cancer. It is also used to evaluate various symptoms such as abnormal bleeding or fatigue, especially in women postmenopause or those with a family history of ovarian cancer. Though not a definitive diagnostic tool, the CA 125 test plays an essential role in assessing health risks related to ovarian abnormalities, making it a vital part of general wellness evaluations. Ensuring early detection of potential risks can significantly benefit treatment outcomes.